Chong-Pyoung Chung

This inventor holds 30 USPTO granted patents and 19 published patent applications, plus 5 CIPO patents and 26 EPO patents, primarily in Peptide Therapeutics. Top assignees: Nano Intelligent Biomedical Engineering Corporation Co. Ltd., Seoul National University, Nibec Co., Ltd.. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chong-Pyoung Chung. Retrieved from https://idiyas.com/inventor/chong-pyoung-chung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 19)

% Patents Active = 93.3

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 26 (Patent Applications = 44)

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 51(Granted Patents)

Location History:

Songpa-gu, KR (2013)
Seoul, KR (2011 - 2023)

Company Filing History:

19 out of 19

Nano Intelligent Biomedical Engineering Corporation Co. Ltd.

patents

17 out of 1,779

Seoul National University

Chungbuk National University Industry-Academic Cooperation Foundation

patents

7. 1 out of 1

Nano Intelligent Biomedical Engineering Corporation

patent

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Bone Regeneration

Peptide Therapeutics

Anti-Inflammatory

Cancer Treatment

Stem Cells

Biomarkers

Pharmaceutical Composition

Tissue Engineering

Osteogenesis

Biofilms

Gingivoperiodontitis

Obesity Treatment

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12698313 - BONE MORPHOGENETIC PROTEIN-9 AND -10 VARIANTS WITH ENHANCED THERAPEUTIC EFFECT DUE TO REDUCED SIDE EFFECTS OF ECTOPIC OSSIFICATION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME (2026-08-04),

2. 12545704 - PEPTIDE FOR TREATING INFLAMMATION AND WOUNDS (2026-02-10),

3. 12486303 - NOVEL USE OF PEPTIDE FOR INHIBITING FUNCTIONS AND EXPRESSIONS OF MULTIPLE DISEASE BIOMARKERS (2025-12-02),

4. 12161518 - Composition for treating and preventing gingivoperiodontitis or peri-implantitis, and interdental brush coated with same (2024-12-10),

5. 11760792 - GRP78-derived peptide for identifying high-efficiency stem cells (2023-09-19),

6. 11384120 - Peptide capable of binding to biomarker for inflammatory and metabolic diseases, and use thereof (2022-07-12),

7. 11365218 - Bifunctional peptide having capability to reduce inflammation and capability to facilitate differentiation of stem cells into chondrocytes and use thereof (2022-06-21),

8. 11179445 - Pharmaceutical composition and biomaterial comprising fusion peptide in which bone tissue-selective peptide bound to parathyroid hormone (PTH) or fragment thereof (2021-11-23),

9. 10836795 - Dual functional novel peptide having cell permeability and bone tissue regeneration ability, and use thereof (2020-11-17),

10. 10821065 - Peptide for inhibiting biofilms (2020-11-03),

11. 10815312 - Bifunctional peptide having capability to permeate cells and capability to regenerate muscles and use thereof (2020-10-27),

12. 10406264 - Peptide having titanium-binding ability (2019-09-10),

13. 10232083 - Mimetic tissue structure containing extracellular matrix protein-bone mineral complex and method for manufacturing same (2019-03-19),

14. 10155022 - Fat accumulation inhibitory peptide and pharmaceutical composition for preventing or treating obesity containing the same (2018-12-18),

15. 10066212 - Method for preparing induced pluripotent stem cells using synthetic peptide (2018-09-04),

Title: Chong-Pyoung Chung: Pioneering Innovations in Seoul

Introduction:

Chong-Pyoung Chung, a visionary inventor based in Seoul, South Korea, has made significant contributions to the field of biotechnology with a remarkable portfolio of 26 patents. His relentless pursuit of innovation and passion for creating technologies that enhance lives have established him as a leading figure in the realm of scientific advancement.

Latest Patents:

Chung's latest patents showcase his ingenuity and commitment to pushing the boundaries of stem cell research and disease treatment. One such invention involves a GRP78-derived peptide for identifying high-efficiency stem cells, revolutionizing the screening process and enhancing the efficacy of stem cell therapy products. Another patent focuses on a peptide capable of binding to biomarkers for inflammatory and metabolic diseases, offering promising prospects for the treatment of various health conditions.

Career Highlights:

Throughout his illustrious career, Chong-Pyoung Chung has made significant strides in the field of biomedicine. He has dedicated his expertise to companies such as Nano Intelligent Biomedical Engineering Corporation Co. Ltd. and Seoul National University R&DB Foundation, where he has spearheaded groundbreaking research projects and innovative developments in the domain of biotechnology.

Collaborations:

Chung's collaborative efforts with esteemed colleagues, including Jue-Yeon Lee and Yoon Jeong Park, have been instrumental in driving forward cutting-edge research initiatives and fostering a culture of innovation within the scientific community. His ability to collaborate effectively with peers has led to the successful realization of pioneering inventions and advancements in the field of biotechnology.

Conclusion:

Chong-Pyoung Chung's exceptional contributions to the realm of innovation and invention stand as a testament to his visionary leadership and unwavering dedication to advancing scientific knowledge. His pioneering work in stem cell research and disease treatment has not only transformed the landscape of biomedicine but has also paved the way for future breakthroughs in the field. Chung's legacy as a visionary inventor in Seoul, South Korea, continues to inspire generations of innovators and researchers to push the boundaries of possibility in pursuit of scientific excellence.

Profile summary based on public USPTO records.